Acurx Pharmaceuticals Secures New Patent for Innovative DNA Polymerase IIIC Inhibitors Acurx Pharmaceuticals has been granted a new patent for DNA Polymerase IIIC inhibitors, enhancing its portfolio in antibiotic development and treatment for severe bacterial infections.

Acurx Pharmaceuticals Secures New Patent for Innovative DNA Polymerase IIIC Inhibitors #United_States #Staten_Island #Acurx_Pharmaceuticals #Antibiotic_Development #DNA_Polymerase_IIIC

Acurx Pharmaceuticals Secures New Patent for Innovative Antibiotic Technology Acurx Pharmaceuticals has been awarded a new patent for its cutting-edge DNA Polymerase IIIC inhibitors, strengthening its IP in antibiotic development.

Acurx Pharmaceuticals Secures New Patent for Innovative Antibiotic Technology #United_States #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals #DNA_Polymerase_IIIC

Acurx Pharmaceuticals Secures Patent in India for Innovative Antibiotic Technology Acurx Pharmaceuticals has been granted a new patent in India for its pioneering DNA Polymerase IIIC inhibitors aimed at tackling tough bacterial infections.

Acurx Pharmaceuticals Secures Patent in India for Innovative Antibiotic Technology #India #New_York #Acurx_Pharmaceuticals #DNA_Polymerase_IIIC #Antibiotic_Innovation

Acurx Pharmaceuticals Expands Patent Portfolio in Japan for Antibiotic Development Acurx Pharmaceuticals has secured a new patent in Japan for DNA Polymerase IIIC inhibitors, advancing its innovative antibiotics targeting serious bacterial infections.

Acurx Pharmaceuticals Expands Patent Portfolio in Japan for Antibiotic Development #Japan #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals #DNA_Polymerase_IIIC